Durata Therapeutics, Inc.
Durata Therapeutics, Inc. (DRTX) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 89 transactions totaling $106.2M, demonstrating a bullish sentiment with $103.0M in net insider flow. The most recent transaction on Nov 17, 2014 involved a transaction of 6,250 shares valued at $0.
DRTX Insider Activity Summary
Who Is Buying DRTX Stock?
No significant insider buying has been recorded for DRTX in the recent period.
Who Is Selling DRTX Stock?
No significant insider selling has been recorded for DRTX in the recent period.
Is Durata Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DRTX is bullish with an Insider Alignment Score of 99/100 and a net flow of $103.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
DRTX Frequently Asked Questions
Understanding DRTX Insider Activity
Insider trading at Durata Therapeutics, Inc. (DRTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading DRTX stock, having executed 89 transactions in the past 90 days. The most active insider is Capital Partners III Llc Aisling (Executive), who has made 2 transactions totaling $10.0M.
Related Tools
Track Durata Therapeutics, Inc. Insider Activity
Get notified when executives and directors at DRTX file new Form 4 transactions